Fig. 3
From: LGR5 overexpression confers poor relapse-free survival in breast cancer patients
Kaplan-Meier analysis of the association of LGR5 and β-catenin expression with RFS in breast cancer patients. a LGR5 expression level in all patients. b LGR5 expression level in non-TNBC patients. c LGR5 expression level in TNBC patients. d β-catenin expression level in all patients. e β-catenin expression level in non-TNBC patients. f β-catenin expression level in TNBC patients. TNBC: triple-negative breast cancer